PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus Infection-Reference-Cited by-同舟云学术

PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus Infection

Published:2022-07-29 Issue:9 Volume:23 Page:3593-3601
ISSN:1525-7797
Container-title:Biomacromolecules
language:en
Short-container-title:Biomacromolecules

Author:

Hauptstein Niklas¹^ORCID,Dirauf Michael²³,Wittwer Kevin⁴,Cinar Gizem²³,Siering Oliver⁴,Raschig Martina¹,Lühmann Tessa¹^ORCID,Scherf-Clavel Oliver¹,Sawatsky Bevan⁴^ORCID,Nischang Ivo²³^ORCID,Schubert Ulrich S.²³^ORCID,Pfaller Christian K.⁴,Meinel Lorenz¹⁵^ORCID

Affiliation:

1. Institute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany

2. Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstr. 10, 07743 Jena, Germany

3. Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743 Jena, Germany

4. Paul-Ehrlich-Institute, Division of Veterinary Medicine, Paul-Ehrlich-Str. 51-59, 63225 Langen, Germany

5. Helmholtz Institute for RNA−Based Infection Research (HIRI), Josef-Schneider-Straße 2, 97080 Würzburg, Germany

Funder

Bundesministerium f?r Bildung und Forschung

Th?ringer Aufbaubank

Freistaat Th?ringen

European Regional Development Fund

European Social Fund

Publisher

American Chemical Society (ACS)

Subject

Materials Chemistry,Polymers and Plastics,Biomaterials,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biomac.2c00358

Reference53 articles.

1. Bioconjugation strategies and clinical implications of Interferon-bioconjugates

2. EMA. Pegasys INN-Peginterferon alpha 2a. https://www.ema.europa.eu/en/documents/product-information/pegasys-epar-product-information_en.pdf (accessed June 5, 2022).

3. EMA. PegIntron 50 micrograms powder and solvent for solution for injection. https://ec.europa.eu/health/documents/community-register/2016/20160629135304/anx_135304_en.pdf (accessed June 5, 2022).

4. EMA. Besremi 250 micrograms/0.5 mL solution for injection in pre-filled pen. https://www.ema.europa.eu/en/documents/product-information/besremi-epar-product-information_en.pdf (accessed June 5, 2022).

5. Decoding type I and III interferon signalling during viral infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Modeling in Drug Delivery: Polymer Protective Coatings as Case Study;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

2. Determination of ω -end functionalities in tailored poly(2-alkyl-2-oxazoline)s by liquid chromatography and mass spectrometry;Royal Society Open Science;2024-02

3. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

4. Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2;ACS Biomaterials Science & Engineering;2023-11-21

5. PEG-Lipids: Quantitative Study of Unimers and Aggregates Thereof by the Methods of Molecular Hydrodynamics;Analytical Chemistry;2023-07-07